Trethera Announces Prostate Cancer Poster Presentation at the American Association for Cancer Research Annual Meeting
Los Angeles, March 22, 2022 — Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for the treatment of cancer and autoimmune diseases, announced an upcoming poster presentation at the American Association for Cancer Research (AACR) Annual Meeting. Dr. Caius Radu, of the University of California Los Angeles, […]